Brittany Smith
Psychiatric/Mental Health · Clinton, LANPI 1225210909
Payments from drug & device makers
Across 265 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Neurocrine Biosciences, Inc.$1K
- AbbVie$812
- Johnson & Johnson$427
- Otsuka America Pharmaceutical, Inc.$320
- Axsome Therapeutics, Inc.$313
- plus $1K from 14 others
What the payments were for
- Food & beverage$5,32699%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 64 | $1,151 |
| Neurocrine Biosciences, Inc. | 45 | $1,023 |
| AbbVie | 46 | $812 |
| Johnson & Johnson | 14 | $427 |
| Otsuka America Pharmaceutical, Inc. | 16 | $320 |
| Axsome Therapeutics, Inc. | 11 | $313 |
| Vanda Pharmaceuticals Inc. | 10 | $281 |
| Ironshore Pharmaceuticals Inc. | 18 | $252 |
| Corium, LLC | 9 | $213 |
| Supernus Pharmaceuticals, Inc. | 9 | $171 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| Alkermes, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 2 | $48 |
| Tris Pharma Inc | 3 | $45 |
| Adlon Therapeutics L.p. | 3 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Lundbeck LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Avanir Pharmaceuticals, Inc. | 1 | $23 |
| Indivior Inc. | 1 | $15 |
How this compares
$5,385 in reported general payments places this provider in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $110,125 |
| Invega SustennaPaliperidone Palmitate | 36 | $106,965 |
| CaplytaLumateperone Tosylate | 49 | $85,672 |
| VraylarCariprazine Hcl | 38 | $48,864 |
| Abilify MaintenaAripiprazole | 14 | $38,146 |
| VyvanseLisdexamfetamine Dimesylate | 47 | $17,695 |
| NuedextaDextromethorphan Hbr/Quinidine | 11 | $16,317 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 288 | $9,090 |
| Paliperidone ErPaliperidone | 46 | $4,334 |
| Vilazodone Hcl | 35 | $2,891 |
| Lisdexamfetamine Dimesylate | 12 | $2,551 |
| Oxcarbazepine | 34 | $2,343 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 58 | $1,880 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 47 | $1,650 |
| Doxepin Hcl | 25 | $1,166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,023 | $110,12513 claims |
| Johnson & JohnsonInvega Sustenna | $427 | $106,96536 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,151 | $85,67249 claims |
| AbbVieVraylar | $812 | $48,86438 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $320 | $38,14614 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $32 | $17,69547 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $23 | $16,31711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Clinton
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
- Lecy AlbaradoScott$34K
- Michelle DyerLake Charles$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.